Scottish Health Innovations Ltd
SUBMIT AN IDEA
Do you have an idea that may improve patient care? You can submit your idea on-line. Click here to find out more.
Device for harvesting oesophageal tissue plus a Rapid Molecular Based Screening Assay for Barrett’s Oesophagus
|
New technology for screening for the presence of Barrett’s Oesophagus has been developed. The technology combines a device which allows for easy and accurate harvesting of the desired site with an improved diagnostic tool. Market opportunity Social factors and an ageing population are causing the global incidence of Barrett’s Oesophagus (Barrett’s) to increase. It is estimated that 10% of patients with recurrent gastroesophageal reflux disease (GORD) will progress to Barrett’s. This equates to approximately 1-2% of the population. It has been estimated that there are approximately one million people in the USA with diagnosed pre-cancerous Barrett’s. Clinical Benefit Current testing methods typically take 5 days and require to be conducted by experienced senior clinical staff plus dedicated pathology facilities; however results using this new technology can be obtained in twenty minutes via Enzyme-Linked Immunosorbent Assay (ELISA) techniques. The sensitivity and specificity of the molecular markers have been demonstrated and offer an attractive alternative to the current biopsy technique; as well as being a potential tool for population screening or surveillance. Summary of technology
If you would like to request more information about this project please click This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
Featured Product
Multifocal Imager 3GEN
 |
 |
 |
 |
 |
 |
